BMO Capital has initiated coverage on Doximity Inc (DOCS) with a Market Perform rating as of November 12, 2025. The stock is currently priced at $49.72.
Doximity, headquartered in San Francisco, California, operates an online platform for medical professionals. The company provides marketing, hiring, and workflow solutions tailored for pharmaceutical manufacturers, health systems, and medical recruiting firms. With a market capitalization of $10.2 billion, Doximity has a trailing twelve-month price-to-earnings (P/E) ratio of 43.25 and earnings per share (EPS) of 1.16.
Upcoming earnings are expected on August 4, 2026, with an estimated EPS of $0.38 and revenue of $165.1 million. The previous quarter's performance showed an EPS of $0.45, surpassing estimates by 16.4%.
The analyst consensus as of November 1, 2025, includes 8 Strong Buy, 8 Buy, 8 Hold, 2 Sell, and no Strong Sell ratings, indicating a general positive outlook among analysts.
Such decisions reflect BMO Capital’s assessment of Doximity's market position and growth potential within the healthcare industry.